154 related articles for article (PubMed ID: 14575773)
1. Modelling measles re-emergence as a result of waning of immunity in vaccinated populations.
Mossong J; Muller CP
Vaccine; 2003 Nov; 21(31):4597-603. PubMed ID: 14575773
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the Population Susceptibility Against Measles in Slovakia.
Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H
Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355
[TBL] [Abstract][Full Text] [Related]
3. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
[TBL] [Abstract][Full Text] [Related]
4. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
[TBL] [Abstract][Full Text] [Related]
5. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.
Mossong J; Nokes DJ; Edmunds WJ; Cox MJ; Ratnam S; Muller CP
Am J Epidemiol; 1999 Dec; 150(11):1238-49. PubMed ID: 10588085
[TBL] [Abstract][Full Text] [Related]
6. Waning of vaccine-induced immunity: is it a problem in Africa?
Aaby P; Cisse B; Simondon F; Samb B; Soumaré M; Whittle H
Am J Epidemiol; 1999 Feb; 149(4):304-5. PubMed ID: 10025471
[TBL] [Abstract][Full Text] [Related]
7. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
[TBL] [Abstract][Full Text] [Related]
8. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
[TBL] [Abstract][Full Text] [Related]
9. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.
Phadke VK; Bednarczyk RA; Salmon DA; Omer SB
JAMA; 2016 Mar; 315(11):1149-58. PubMed ID: 26978210
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
[TBL] [Abstract][Full Text] [Related]
11. Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.
Nkowane BM; Bart SW; Orenstein WA; Baltier M
Am J Public Health; 1987 Apr; 77(4):434-8. PubMed ID: 3826461
[TBL] [Abstract][Full Text] [Related]
12. An increasing, potentially measles-susceptible population over time after vaccination in Korea.
Kang HJ; Han YW; Kim SJ; Kim YJ; Kim AR; Kim JA; Jung HD; Eom HE; Park O; Kim SS
Vaccine; 2017 Jul; 35(33):4126-4132. PubMed ID: 28669617
[TBL] [Abstract][Full Text] [Related]
13. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.
Parker AA; Staggs W; Dayan GH; Ortega-Sánchez IR; Rota PA; Lowe L; Boardman P; Teclaw R; Graves C; LeBaron CW
N Engl J Med; 2006 Aug; 355(5):447-55. PubMed ID: 16885548
[TBL] [Abstract][Full Text] [Related]
14. Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland.
Janaszek W; Gay NJ; Gut W
Vaccine; 2003 Jan; 21(5-6):473-8. PubMed ID: 12531646
[TBL] [Abstract][Full Text] [Related]
15. Waning immunity and subclinical measles infections in England.
Glass K; Grenfell BT
Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
[TBL] [Abstract][Full Text] [Related]
16. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
Hickman CJ; Hyde TB; Sowers SB; Mercader S; McGrew M; Williams NJ; Beeler JA; Audet S; Kiehl B; Nandy R; Tamin A; Bellini WJ
J Infect Dis; 2011 Jul; 204 Suppl 1():S549-58. PubMed ID: 21666212
[TBL] [Abstract][Full Text] [Related]
17. The role of herd immunity in control of measles.
Black FL
Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
[TBL] [Abstract][Full Text] [Related]
18. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey.
Lowther SA; Curriero FC; Kalish BT; Shields TM; Monze M; Moss WJ
Lancet; 2009 Mar; 373(9668):1025-32. PubMed ID: 19211140
[TBL] [Abstract][Full Text] [Related]
19. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
20. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
